Condition
Cryoablation
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 4 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
4 shownCryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary MetastasesNCT06265350 · 2024-02-02
RECRUITINGOne-stop Diagnosis and Treatment for Suspected Lung Cancer: Combined RBS, nClE, OBCT and AblationNCT07521618 · 2026-04-01
NOT_YET_RECRUITINGRandomized Trial of HIFU vs. Cryo for Prostate CancerNCT06929065 · 2023-04-01
COMPLETEDComparison of Microwave Ablation With Cryoablation for Breast TumorNCT03286413 · 2016-01-01
UNKNOWNCommon interventions
Leading sponsors
Trial status mix
COMPLETED1
NOT_YET_RECRUITING1
RECRUITING1
UNKNOWN1
Phase mix
NA4
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.